Seeking Slice of Primary Screening Market, Fisher s Cellomics Unit Inks Pact with Evotec ... | GenomeWeb

Cellomics signed a co-development and co-marketing agreement with Evotec Technologies this week that will provide the firm with its first play in the high-end market of using cell-analysis instruments for primary screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.